Microdissected “cuboids” for microfluidic drug testing of intact tissues-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Microdissected “cuboids” for microfluidic drug testing of intact tissues

Published:2021 Issue:1 Volume:21 Page:122-142
ISSN:1473-0197
Container-title:Lab on a Chip
language:en
Short-container-title:Lab Chip

Author:

Horowitz Lisa F.¹²³⁴^ORCID,Rodriguez Adan D.¹²³⁴^ORCID,Au-Yeung Allan¹²³⁴⁵^ORCID,Bishop Kevin W.¹²³⁴⁶^ORCID,Barner Lindsey A.⁶²³⁴,Mishra Gargi⁷⁸³⁴⁹,Raman Aashik¹²³⁴,Delgado Priscilla¹²³⁴,Liu Jonathan T. C.¹²³⁴⁶,Gujral Taranjit S.⁹⁸³⁴,Mehrabi Mehdi¹⁰¹¹¹²¹³,Yang Mengsu⁵¹⁴¹⁵,Pierce Robert H.⁷⁸³⁴,Folch Albert¹²³⁴

Affiliation:

1. Department of Bioengineering

2. University of Washington

3. Seattle

4. USA

5. Department of Biomedical Sciences

6. Department of Mechanical Engineering

7. Clinical Research Division

8. Fred Hutchinson Cancer Research Center

9. Human Biology Division

10. Department of Mechanical and Aeronautical Engineering

11. University of Pretoria

12. Pretoria

13. South Africa

14. City University of Hong Kong

15. China

Abstract

A microfluidic platform permits multiple drug testing of uniformly-sized microscale “cuboids” of live tissue with well-preserved microenvironments.

Funder

CoMotion, University of Washington

National Science Foundation

National Cancer Institute

Juno Therapeutics

Research Grants Council, University Grants Committee

Consejo Nacional de Ciencia y Tecnología

DOD Prostate Cancer Research Program

Publisher

Royal Society of Chemistry (RSC)

Subject

Biomedical Engineering,General Chemistry,Biochemistry,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/LC/D0LC00801J

Reference75 articles.

1. Are animal models predictive for humans?

2. Functional precision cancer medicine—moving beyond pure genomics

3. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

4. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

5. Modeling Pancreatic Cancer with Organoids

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An end-to-end workflow for nondestructive 3D pathology;Nature Protocols;2024-01-23

2. Engineering Heterogeneous Tumor Models for Biomedical Applications;Advanced Science;2023-11-09

3. An end-to-end workflow for non-destructive 3D pathology;2023-08-06

4. Standardization of organoid culture in cancer research;Cancer Medicine;2023-04-20

5. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor‐on‐a‐Chip;Advanced Healthcare Materials;2023-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3